scispace - formally typeset
S

Sophie Jallat

Researcher at Transgene SA

Publications -  15
Citations -  2523

Sophie Jallat is an academic researcher from Transgene SA. The author has contributed to research in topics: Alpha (ethology) & Neutrophil elastase. The author has an hindex of 9, co-authored 15 publications receiving 2471 citations.

Papers
More filters
Journal ArticleDOI

Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo

TL;DR: The respiratory epithelium is a potential site for somatic gene therapy for the common hereditary disorders alpha 1-antitrypsin (alpha 1AT) deficiency and cystic fibrosis by infecting epithelial cells of the cotton rat respiratory tract in vitro and in vivo.
Journal ArticleDOI

Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.

TL;DR: The ΔF508 mutation seems to have two major consequences, an abnormal translocation of the CFTR protein which limits membrane insertion, and an abnormal function in mediating Cl- transport.
Journal ArticleDOI

cDNA cloning and expression of a hamster α‐thrombin receptor coupled to Ca2+ mobilization

TL;DR: To clone a thrombin receptor cDNA, selective amplification of mRNA sequences displaying homology to the transmembrane domains of G‐protein‐coupled receptor genes was performed by polymerase chain reaction.
Journal ArticleDOI

Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase.

TL;DR: Results suggest that in cigarette smokers, the alveolar macrophage can modulate the activity of alpha 1AT as an inhibitor of neutrophil elastase and thus play a role in the pathogenesis of emphysema associated with cigarette smoking.
Journal ArticleDOI

Synthesis in E. coli of alpha 1-antitrypsin variants of therapeutic potential for emphysema and thrombosis.

TL;DR: The characterization of two α1-AT analogues produced in Escherichia coli are described, one of which is not only fully active as an elastase inhibitor but is also resistant to oxidative inactivation.